Paper Review Records
全部论文审稿周期
18 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
136
天
Real-World Economic Burden Associated with Progressive Pulmonary Fibrosis in the US: An Administrative Claims Database Analysis
作者
Joseph Yang; Bonnie H. Bui; Tim Bancroft; Andrea Steffens; Rebecca Fee; Bijan J. Borah展开收起
作者单位
1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Optum, Inc., Eden Prairie, USA; 3. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, USA展开收起
143
天
Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review
作者
Anna L. Heilig; Wilbert B. van den Hout; M. Elske van den Akker-van Marle展开收起
作者单位
1. Department of Biomedical Data Science, Leiden University Medical Center, Leiden, The Netherlands展开收起
61
天
Using Proportional and Absolute Shortfall in Reimbursement Decision-Making in the Netherlands: Implications for Oncology Drugs for Older Patients
作者
Vivian Reckers-Droog; Steef Redeker; Jan Busschbach; Sylvia Vijgen; Angèl Link; Lonneke Timmers展开收起
作者单位
1. Erasmus School of Health Policy and Management, Section Health Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands; 2. National Health Care Institute, Diemen, The Netherlands; 3. Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus University Medical Center, Rotterdam, The Netherlands展开收起
262
天
Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within Oncology
作者
Brian Reddy; Claire Telford; Apoorva Ambavane; Sugam Mahajan; J. Jaime Caro展开收起
作者单位
1. Pfizer Healthcare Ireland, Dublin, Ireland; 2. Pfizer Inc., New York City, USA; 3. ThermoFisher, Dubai, UAE; 4. ThermoFisher, Gurgaon, India; 5. ThermoFisher, Waltham, USA; 6. McGill University, Montreal, Canada展开收起
187
天
Application of a Prevalence-Adjusted Cost-Effectiveness Threshold Framework for Pulmonary Arterial Hypertension
作者
Adnan Alsumali; Vasco M. Pontinha; Benjamin G. Cohen; Meghan Levy; William V. Padula展开收起
作者单位
1. Merck & Co., Inc., Rahway, USA; 2. Department of Pharmacotherapy and Outcomes Research, VCU School of Pharmacy, Virginia Commonwealth University, Richmond, USA; 3. Stage Analytics, Suwanee, USA; 4. Department of Pharmaceutical and Health Economics, Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, USA; 5. The Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, USA展开收起
60
天
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天